FDA questions Takeda & more: 5 GI industry key notes

Here are five updates from gastroenterology companies and practices from the past week:

The FDA sent Takeda a questioning letter in response to the company's biologics license application concerning the subcutaneous formulation of Entyvio, a maintenance therapy for ulcerative colitis.

Baptist Medical Center in Jacksonville, Fla., built what it believes to be the region's first gastroesophageal reflux center.

South Denver Gastroenterology opened a clinic and endoscopy center in Castle Rock, Colo.

Conmed is leaving the NASDAQ and transferring its listing to the New York Stock Exchange.

Minneapolis-based Colon & Rectal Surgery Associates will join Infinite Health Collaborative in the spring.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast